Investor conferences. TORONTO, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc.(“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing diagnostic and therapeutic options for septic shock as well as commercializing a new proprietary platform targeting the renal replacement therapy market through its wholly owned subsidiary Dialco Medical Inc. (“Dialco”) today announced its management will participate in the following virtual Investor Conferences:
HC Wainwright 23rd Annual Global Investment, September 13 – 15, 2021 https://hcwevents.com/annualconference/
Benzinga Healthcare Small Cap Conference, September 30, 2021
https://www.benzinga.com/events/small-cap/healthcare/
A.G.P. Alliance Global Partners Fall Biotech & Specialty Pharma Conference, October 13, 2021
Sidoti Microcap Conference, November 18, 2021
https://www.sidoti.com/conferences-events/virtual-microcap-conference-2-ee38l-rnn4l-ekfh9-22kls
Presentation times will be announced closer to the date of each conference.